Cinctive Capital Management LP Has $3.43 Million Stake in Sabra Healthcare REIT, Inc. $SBRA

Cinctive Capital Management LP raised its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 31.1% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 184,001 shares of the real estate investment trust’s stock after purchasing an additional 43,669 shares during the quarter. Cinctive Capital Management LP’s holdings in Sabra Healthcare REIT were worth $3,430,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in SBRA. Vanguard Group Inc. grew its position in Sabra Healthcare REIT by 0.5% during the third quarter. Vanguard Group Inc. now owns 34,948,785 shares of the real estate investment trust’s stock worth $651,445,000 after buying an additional 179,670 shares in the last quarter. Geode Capital Management LLC raised its holdings in Sabra Healthcare REIT by 0.8% in the 2nd quarter. Geode Capital Management LLC now owns 6,613,185 shares of the real estate investment trust’s stock valued at $121,960,000 after acquiring an additional 55,200 shares in the last quarter. Bank of America Corp DE lifted its position in shares of Sabra Healthcare REIT by 9.4% in the 3rd quarter. Bank of America Corp DE now owns 5,224,116 shares of the real estate investment trust’s stock worth $97,378,000 after acquiring an additional 447,528 shares during the period. JPMorgan Chase & Co. lifted its position in shares of Sabra Healthcare REIT by 33.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,589,253 shares of the real estate investment trust’s stock worth $66,904,000 after acquiring an additional 903,841 shares during the period. Finally, Dimensional Fund Advisors LP grew its holdings in shares of Sabra Healthcare REIT by 2.4% during the 3rd quarter. Dimensional Fund Advisors LP now owns 3,399,083 shares of the real estate investment trust’s stock worth $63,358,000 after purchasing an additional 78,586 shares in the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Trading Down 0.8%

SBRA stock opened at $20.62 on Monday. Sabra Healthcare REIT, Inc. has a 1-year low of $15.75 and a 1-year high of $21.07. The firm has a market cap of $5.20 billion, a P/E ratio of 32.22, a P/E/G ratio of 1.66 and a beta of 0.64. The business’s 50 day moving average is $19.65 and its 200-day moving average is $19.01. The company has a current ratio of 4.29, a quick ratio of 4.29 and a debt-to-equity ratio of 0.90.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). The company had revenue of $201.35 million during the quarter, compared to analyst estimates of $201.97 million. Sabra Healthcare REIT had a return on equity of 5.63% and a net margin of 20.09%.The company’s quarterly revenue was up 16.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Equities analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 27th. Shareholders of record on Friday, February 13th were paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 5.8%. The ex-dividend date was Friday, February 13th. Sabra Healthcare REIT’s dividend payout ratio is currently 187.50%.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on SBRA. Scotiabank boosted their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “sector perform” rating in a research report on Monday, March 2nd. Wells Fargo & Company raised their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Weiss Ratings reiterated a “buy (b)” rating on shares of Sabra Healthcare REIT in a research note on Thursday, January 22nd. Jefferies Financial Group reissued a “buy” rating and issued a $22.00 price target on shares of Sabra Healthcare REIT in a report on Monday, December 15th. Finally, Citizens Jmp increased their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research note on Wednesday, February 18th. Five analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $21.90.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.